Literature DB >> 21764174

Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009.

J Wilson1, R Guy, S Elgohari, E Sheridan, J Davies, T Lamagni, A Pearson.   

Abstract

The national mandatory surveillance system for reporting meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England has captured data on the source of reported bacteraemias since 2006. This study analysed episodes of MRSA bacteraemia (N=4404) where a probable source of infection was reported between 2006 and 2009. In 2009, this information was available for one-third of reported episodes of MRSA bacteraemia. Of these, 20% were attributed to intravascular devices and 28% were attributed to skin and soft tissue infection. Sixty-four percent of the patients were male, and urinary tract infection was a significantly more common source of MRSA bacteraemia in males compared with females (12% vs 3%). Detection of bacteraemia within two days of hospital admission does not reliably discriminate between community- and hospital-associated MRSA bacteraemia as community cases are frequently associated with an invasive procedure/device. Between 2006 and 2009, there was a significant decline in the proportion of episodes of MRSA bacteraemia associated with central vascular catheters [incidence rate ratio (IRR) 0.42, 95% confidence interval (CI) 0.29-0.61; P<0.001], peripheral vascular catheters (IRR 0.69, 95% CI 0.48-0.99; P=0.042) and surgical site infection (IRR 0.42, 95% CI 0.25-0.72; P=0.001), and a significant increase in the proportion of episodes of MRSA bacteraemia associated with skin and soft tissue infection (IRR 1.33, 95% CI 1.05-1.69; P=0.017) and attributed to contamination of the specimen (IRR 1.96, 95% CI 1.25-3.06; P=0.003). Since data were not available for all cases, the generalizability of these trends depends on the assumption that records with source data reflect a reasonably random sample of cases in each year. These changes have occurred in the context of a general decline in the rate of MRSA bacteraemia in England since 2006.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764174     DOI: 10.1016/j.jhin.2011.05.013

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Nasal vestibulitis due to targeted therapies in cancer patients.

Authors:  Janelle N Ruiz; Viswanath Reddy Belum; Christine B Boers-Doets; Mini Kamboj; N Esther Babady; Yi-Wei Tang; Tulio A Valdez; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2015-01-22       Impact factor: 3.603

Review 2.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.

Authors:  Helio S Sader; Robert K Flamm; Rodrigo E Mendes; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 4.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

5.  Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections.

Authors:  Michael Z David; Robert S Daum; Arnold S Bayer; Henry F Chambers; Vance G Fowler; Loren G Miller; Belinda Ostrowsky; Alison Baesa; Susan Boyle-Vavra; Samantha J Eells; Sylvia Garcia-Houchins; Philip Gialanella; Raul Macias-Gil; Thomas H Rude; Felicia Ruffin; Julia J Sieth; Joann Volinski; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

6.  Clinical results of linezolid in arthroplasty and trauma MRSA related infections.

Authors:  James Joel; Simon Matthew Graham; Adam Peckham-Cooper; Nectarios Korres; Helen Tsouchnica; Eleftherios Tsiridis
Journal:  World J Orthop       Date:  2014-04-18

7.  Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.

Authors:  Benedikt Huttner; Makoto Jones; Michael A Rubin; Melinda M Neuhauser; Adi Gundlapalli; Matthew Samore
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  An observational prospective study of topical acidified nitrite for killing methicillin-resistant Staphylococcus aureus (MRSA) in contaminated wounds.

Authors:  Anthony D Ormerod; Amjad Aj Shah; Hong Li; Nigel B Benjamin; Gail P Ferguson; Carlo Leifert
Journal:  BMC Res Notes       Date:  2011-10-27

9.  A new journal and new global perspective on infection control and public health.

Authors:  Andreas Voss; Jan Kluytmans; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2012-01-26       Impact factor: 4.887

10.  Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S.

Authors:  Jose A Suaya; Debra F Eisenberg; Christy Fang; Loren G Miller
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.